Longitudinal study investigates epigenetic differences post-SARS-CoV-2 infection, suggesting no significant changes in symptoms.
No persistent epigenetic age- or DNAm based differences due to Long-COVID or SARS-CoV-2 infection were detected in our cohorts.
No takes yet. Share an insight, caveat, or question.
Bohlin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: